>>I asked Jonae if there were any other ICEs being marketed by other companies. She said that levofloxicin is a single isomer (antibiotic) of offloxicin (sp?) that J&J is marketing. She estimated the market for levofloxicin is $700 million. What they gained with the ICE was more flexibility of usage, better side effect profile, etc. I couldn't find anything resembling offloxicin in the top 200 list at RxList.com--perhaps it is no longer on the market.<<
The parent of Levofloxacin is Levaquin, produced by Ortho-McNeil. Curiously, Levofloxacin is "more active against gram-positive organisms such as S. pneumoniae, including pneumococcal strains highly resistant to penicillin" (quoting from The in-this-instance-deeply-respected Medical Letter). This is evidence that optically-pure versions of existing drugs can have different pharmacological effects than the racemic version.
>>The ICE of thamilomide is used to treat leprosy. Don't know the pharmaceutical company there.<<
Celgene.
>>At home, sick, going through trading files, I see SEPR, 7/27/97, $25.00. Made me feel pretty good to be at $70.<<
Really puts this correction and the initial downsweep in perspective, doesn't it?
Today was eerie. Traded all day in a very narrow range, 69 5/8 to 69 15/16, before the final spike up.
Is it the weekend already?
|
